Thc Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended January 31, 2021
March 29, 2021 at 11:14 am
Share
THC Therapeutics, Inc. announced earnings results for the second quarter ended January 31, 2021. For the second quarter, the company announced operating loss was USD 327,909 compared to USD 394,947 a year ago. Net loss was USD 359,825 compared to USD 867,039 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.07 a year ago. For the half year, operating loss was USD 441,956 compared to USD 567,204 a year ago. Net loss was USD 449,875 compared to USD 1.012 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.08 a year ago.
THC Therapeutics, Inc. is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The dHydronator can also reduce the bacterial count of the cannabis during the drying process. The Company operates in the wellness industry.